Cancer

Medicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA® (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study

70-year-old patient with advanced chemo-refractory anal cancer achieves complete response (CR) in 8 weeks when treated with MDNA11 in combination…

4 weeks ago

Outcomes4Me and CURE® Media Group Partner to Accelerate Patient Access to Innovative Cancer Therapies

Exclusive collaboration empowers patients with cancer through access to evidence-based and informative resources that provide guidance at every stage of…

4 weeks ago

Up to $1.6 Million in Funding Available for NSF Tissue Engineering Research Utilizing the ISS National Lab

Solicitation now open for multiple awards supporting space-based tissue engineering and mechanobiology research KENNEDY SPACE CENTER, Fla., Dec. 4, 2024…

4 weeks ago

New Study Indicates SpotitEarly Detects Multiple Cancers Early By Using AI, Trained Canines And Breath Samples

Innovative platform can identify breast, lung, prostate and colorectal cancers with a single, non-invasive test ENGLEWOOD, N.J., Dec. 4, 2024…

4 weeks ago

Cleerly Raises $106 Million in Funding Led by Insight Partners to Revolutionize Heart Disease Care

DENVER, Dec. 4, 2024 /PRNewswire/ -- Today Cleerly, a leader in advanced cardiovascular imaging, announced the successful closure of its Series…

4 weeks ago

Study published in the New England Journal of Medicine AI Concludes that the Sepsis ImmunoScore™, the First FDA-Authorized AI Tool for Sepsis, has both significant Diagnostic and Predictive Power

Groundbreaking NEJM AI Study Highlights the Ability of Prenosis' Sepsis ImmunoScore™ to Holistically Predict Adverse Outcomes, Ushering in a New…

4 weeks ago

BioFuse Medical Technologies Announces New CEO and Strategic Appointments to Advisory Team

TAMPA, FL / ACCESSWIRE / December 4, 2024 / BioFuse Medical Technologies proudly announces the appointment of Rick Earley as…

4 weeks ago

Bispecific Antibody, APVO442, Differentiated to Treat Prostate Cancer with Precision Tumor Targeting and Reduced Risk of Side Effects

Powered by Aptevo's proprietary ADAPTIR-FLEX®platform, antibody innovation targeting difficult-to-treat cancers SEATTLE, WA / ACCESSWIRE / December 4, 2024 / Aptevo…

4 weeks ago

Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration

Full-service medical oncology practice to pioneer the use of SRT to treat companion animals for both home and veterinary clinic…

4 weeks ago

Adaptive Research Welcomes Western Radiation Oncology to Expand Community Access to Pioneering Cancer Treatment Trials

SAN FRANCISCO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Adaptive Research and Western Radiation Oncology (WRO) have announced that WRO has…

4 weeks ago